DCAI

CAS No. 299165-92-7

DCAI( —— )

Catalog No. M27763 CAS No. 299165-92-7

DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 188 In Stock
5MG 227 In Stock
10MG 318 In Stock
25MG 535 In Stock
50MG 736 In Stock
100MG 1042 In Stock
200MG Get Quote In Stock
500MG 2093 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DCAI
  • Note
    Research use only, not for human use.
  • Brief Description
    DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
  • Description
    DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    mTOR (FKBP12)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    299165-92-7
  • Formula Weight
    243.13
  • Molecular Formula
    C11H12Cl2N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1[nH]c2cc(Cl)cc(Cl)c2c1CCN
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Maria Raffaella Martina, et al. The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands. J Med Chem. 2013 Feb 14;56(3):1041-51.
molnova catalog
related products
  • Kisspeptin 10 (dog)

    Endogenous ligand for the canine KISS1 receptor (Kisspeptin receptor or GPR54). Stimulates section of luteinizing hormone, follicle stimulating hormone and estradiol in vivo.

  • GSK484 hydrochloride

    GSK484 hydrochloride (GTPL8577) is a specifc and reversible peptidyl arginine deiminase 4 (PAD4) inhibitor.

  • CCI-006

    CCI-006 is a selective inhibitor and chemosensitizer of MLL-rearranged leukemia cells. It inhibits mitochondrial respiration resulting in insurmountable mitochondrial depolarization and a pro-apoptotic unfolded protein response in a subset of MLL-r leukemia cells.